MEDNAX's GAAP loss for 3 months of 2022 was $21.192 million, compared to a profit of $17.634 million in the previous year. Revenue increased 7.9% to $482.229 million from $446.753 million a year earlier.
MEDNAX's GAAP loss for 3 months of 2022 was $21.192 million, compared to a profit of $17.634 million in the previous year. Revenue increased 7.9% to $482.229 million from $446.753 million a year earlier. 
English (US) 